Resumen de: WO2026078280A1
The present invention relates to a breast phantom, comprising: a first hydrogel that forms a simulated phantom of normal breast tissue and a second hydrogel that forms a simulated phantom of cancerous breast tissue, wherein the first hydrogel comprises cross-linked 2-hydroxyethyl acrylate and the second hydrogel comprises cross-linked methacrylate hyaluronic acid. The present invention also relates to the method of preparing said phantom and to its use.
Resumen de: US20260105608A1
0000 Systems and methods are provided for processing image data generated by a medical imaging system such as an ultrasound or echocardiogram system using artificial intelligence and machine learning to determine a presence of one or more congenital heart defects (CHDs) and/or other cardiovascular anomalies in the image data in a manner that is agnostic to the type of imaging system, software, and/or hardware. Image data from various types imaging systems, software, and/or hardware, having various styles of imaging data generated may be processed to determine image styles. Input image data for analysis may then be processed together with representative styles of image data to generate styled input images for each style. The styled input images may be processed by an image analyzer to detect one or more cardiovascular anomalies in the styled image data, for example. Alternatively, training data may be styled and used to train the image analyzer.
Resumen de: US20260106031A1
Provided is a computer-implemented device for generating a type-Il (T2DM) diabetic status prediction, including: a memory comprising a diabetic status prediction model; and a processor in communication with the memory, the processor configured to: receive a voice sample from the subject; extract at least one voice biomarker feature value from the voice sample for at least one predetermined voice biomarker feature; determine the type-II (T2DM) diabetic status prediction for the subject based on the at least one voice biomarker feature value and the diabetic status prediction model; and output, to an output device, the type-II (T2DM) diabetic status prediction for the subject or an output based on the diabetic status prediction.
Resumen de: US20260102758A1
The subject invention pertains a stable, three-dimensional (3D) photocatalyst composition comprising TiO2 doped with carbon derived from lignin. The photocatalyst composition has a stable, hollow, spherical or spheroid nanoparticle structure, which improves photodegradation under visible light irradiation over unmodified TiO2 photocatalysts. The subject invention also provides methods of preparing the photocatalyst, as well as methods using the photocatalyst to remediate contaminants such as pharmaceuticals, pathogens and persistent organic pollutants.
Resumen de: WO2026080101A2
The portable sensor system (100) includes a containment portion (102) and a sensor portion (104). The containment portion (102) may include a shipping container such as a jar. The sensor portion (104) may include a cap (106) that may be selectively coupled with the containment portion (102). The cap (106) may include a battery module (108), a processing module (110), and a sensor module (112). In a specific example, the portable sensor system (100) may be provided in four layers (a battery module layer (108), a processing module layer (110), a sensor module layer (112), and a coupling mechanism layer (114). The coupling mechanism layer (114) may be configured to selectively lock the cap (106) to the containment portion (102). In a more specific example, one or more of the layers (108, 110, 112, 114) may be 3D printed. The portable sensor system (100) may be utilized as a smart-monitoring device for the presence of a pathogenic bacteria in the shipping container.
Resumen de: WO2026080793A1
A system and method for registering and tracking anatomical structures during surgical procedures by leveraging continuously updated 3D topological data of objects within the surgical field. Registration allows different datasets such as preoperative CT scans and intraoperative 3D scans to be aligned, combined, and transformed into a common coordinate space, enabling more precise surgical planning and execution. Tracking involves continuously registering these datasets over time, monitoring changes in position or orientation, and keeping objects aligned within the common coordinate space, updating the spatial alignment of registered objects multiple times per second, which allows for dynamic monitoring of anatomical structures and surgical tools as they move throughout the procedure. Unlike traditional systems that rely on physical optical markers (OMs) and optical tracker constellations (OTCs), the system and method disclosed herein utilizes the data captured by a 3D scanner to perform Continuous Anatomic Auto Tracking (CAAT).
Resumen de: WO2026078545A1
Synthetic corneal stroma are created though a bioprinting process. The bioprinting process utilizes Digital Light Processing (DLP) in the formation of the corneal stroma. A hydrogel is formed to serve as the basis for the DLP printing. The DLP printing process provides control exposure of the hydrogel to UV light. The bioprinting through the DLP printing process forms a synthetic corneal stroma.
Resumen de: US20260102187A1
0000 Aspects of the disclosure relate to an adjustable implant configured to be implanted into a patient that includes an adjustable portion moveable relative to a housing. The adjustable implant may include various smart components for enhancing operation of the implant. Smart components may include a controller for managing operations and a transducer for communicating ultrasound data with an external interface device. Additional smart components may include a load cell within the housing for measuring an imparted load; a sensor for measuring angular position of the adjustable portion; a dual sensor arrangement for measuring imparted forces; a reed switch; a half piezo transducer; and an energy harvester.
Resumen de: US20260102576A1
A respiratory therapy system for providing continuous positive air pressure (CPAP) to a patient may include a flow generator for generating a supply of breathable gas, a sensor to measure a physical quantity while the breathable gas is supplied, and a computing device. The computing device may be configured to: receive sensor data that is based on measured physical property of the supply of breathable gas; control the flow generator to adjust a property of the supply of breathable gas; display a question and a plurality of selectable responses; receive a first input selecting one of the selectable responses; and display a coaching response corresponding to the selected response.
Resumen de: US20260105916A1
0000 ice control of medical devices in a healthcare facility are disclosed herein. The systems employ continuous speech processing software, voice recognition software, natural language processing software, and other software to permit voice control of the medical devices. Systems are also provided for distinguishing which medical device from among multiple medical devices in a patient room is the particular medical device to be controlled by voice input from a caregiver or a patient.
Resumen de: US20260102624A1
0000 Systems and methods for controlling a mobile defibrillator (AED) unit are provided.
Resumen de: US20260102139A1
0000 Circuitless heart rhythm determination can include capturing a video clip of one or more image frames of a target organ through an ultrasound imaging device and submitting the frames to a classifier that has been trained with an annotated set of images, each of a corresponding heart muscle captured at a specified phase of a heart rhythm with a ground truth indication of the specified phase of the heart rhythm drawn from a separately recorded cycle graph of an electrical signal measured over time for the corresponding heart muscle. In response to the submission, a classification can be received of different portions of the submitted frames according to corresponding phases of the heart rhythm. Finally, a contemporaneous phase of the heart rhythm can be determined in the device without sensing electrical signals by way of a closed-loop sensor circuit affixed proximately to the target heart muscle.
Resumen de: US20260102555A1
An apparatus, system and method for regulating fluid flow are disclosed. An apparatus for infusing fluid into a patient includes a housing, a tube-contact member, a rotating arm, and a tube-retention cover. The housing has an opening on a front side of the housing. The opening is sized to receive a drip chamber having an inlet tube and an outlet tube. The tube-contact member contacts one of the inlet tube and the output tube of the drip chamber when inserted into the opening. The rotating arm is coupled to the tube-contact member and is configured to rotate along an axis. The tube-retention cover is configured to close when the drip chamber is initially loaded into the opening.
Resumen de: US20260102223A1
A dental appliance for a patient includes a body including a first surface and a second surface opposite to the first surface. The second surface defines a channel for receiving a plurality of teeth of the patient. The dental appliance further includes an arrangement of a plurality of features disposed on the first surface of the body. Each of the plurality of features includes a protrusion extending from the first surface opposite to the second surface; a depression extending partially from the first surface wards the second surface; or a through-hole extending from the first surface to the second surface. The arrangement of the plurality of features encodes a feature data representative of a dental appliance information of the dental appliance or a patient information of the patient.
Resumen de: US20260104835A1
0000 A continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays is disclosed, as well as systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Also provided is a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays.
Resumen de: US20260102066A1
A method and system for non-invasively determining continuous total hemoglobin data is provided. The method includes a) using a near infra-red spectrophotometric (NIRS) sensing device on a continuous basis to sense a subject's tissue, the sensing producing NIRS signals; and b) determining continuous total hemoglobin (THb) using the produced NIRS signals.
Resumen de: US20260102067A1
0000 An apparatus for monitoring a person's health conditions. The apparatus has one or more biometric sensors for periodically measuring the person's biometric data, one or more activity sensors for periodically measuring the person's activities, and a circuit functionally coupled to the one or more biometric sensors and the one or more activity sensors, the circuit having an artificial intelligence (AI) engine configured for using a trained AI model for analyzing the person's health condition based on the measurement data collected from the one or more biometric sensors and the one or more activity sensors.
Resumen de: US20260102288A1
A system for creating a tissue interface. The system includes a scanner, at least one processor, and a memory. The scanner is configured to scan a tissue site and generate a signal corresponding to a topography of the tissue site. The at least one processor is configured to receive the signal corresponding to the topography of the tissue site and to receive user input at a user interface identifying a therapy to be applied at the tissue site. The memory is coupled to the at least one processor and is configured to store instructions that when executed by the at least one processor in response to receiving the signal corresponding to the topography of the tissue site cause the system to transform the signal corresponding to the topography of the tissue site into a model site surface and generate a model tissue interface.
Resumen de: US20260102124A1
0000 Certain aspects of the present disclosure relate to methods and systems for providing decision support around glucose management for patients with diabetes. Time-varying inputs including blood glucose, meal intake information, and amount of infused insulin are processed using a machine learning model to obtain predicted glucose levels for a plurality of prediction horizons and uncertainties for the predictions. A confidence interval is generated for each prediction and the confidence intervals are compared to hypo- and hyperglycemic thresholds. If a confidence interval is entirely below or entirely above the hypo- and hyperglycemic thresholds, respectively, then a decision support output is provided.
Resumen de: WO2024254134A2
The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having at least one coating layer provide drug storage and drug release tor the treatment of various diseases, disorders, or conditions, One aspect of the present invention includes a packaged medical device including a medicament. Another aspect of the present invention includes a drug delivery contact lens. A farther aspect of the present invention includes a. method of making a drug delivery contact lens. An additional aspect of the present invention includes a method of using a drug delivery contact lens. A further aspect of the present invention includes a medical device including bimatoprost and N-vinylpyrrolidone.
Resumen de: WO2024252292A1
The bio-printed skin model (1) comprises: - at least one dermal layer (2) comprising at least one polymer matrix and a mixture of fibroblasts and endothelial cells and configured to simulate a human dermal tissue; - at least one epidermal layer (3) comprising at least one mixture of keratinocytes and configured to simulate a human epidermal tissue; wherein the dermal layer (2) comprises at least one inner duct (4) formed by fibroblasts and endothelial cells, configured to simulate a vascular channel of human skin and provided with at least two end stretches communicating with the outside and connectable to a system for active perfusion of substances.
Resumen de: WO2024251724A1
The invention relates to a method for producing a first connection element of a removable dental prosthesis, said connection element being suitable for a sliding connection between a first fit surface of the first connection element and a second fit surface of a second connection element of the removable dental prosthesis. The invention is characterized in that the first connection element is produced by connecting a stability-granting material and a ductile material which forms the first fit surface in an additive multi-material manufacturing method.
Resumen de: KR20260050994A
0001a 본 발명의 다양한 실시예에 따른 수면 장애 개선을 위한 맞춤형 구강 장치의 3D 모델링 방법이 개시된다. 상기 방법은, 상악 모델 및 하악 모델을 포함하는 치아 모델을 생성하는 단계, 상기 치아 모델에 기초하여 윤곽 정보를 생성하는 단계, 상기 윤곽 정보에 기초하여 복수 개의 파츠 모델을 생성하는 단계 및 상기 복수 개의 파츠 모델을 통합하여 구강 장치 모델을 생성하는 단계를 포함할 수 있다.
Resumen de: JP2026065297A
0001 【課題】より精度の高い原発性骨腫瘍の診断支援の実現を提供する。 【解決手段】X線画像による原発性骨腫瘍の診断支援システムであって、前記X線画像を入力した際に畳み込みニューラルネットワークによって骨腫瘍であるかの判定結果を出力する処理手段を備え、前記畳み込みニューラルネットワークが、骨外腫瘍、骨皮質部及び骨内腫瘍の3クラスとして腫瘍存在範囲をアノテーションされた確定診断X線画像を教師データとして学習処理されたものであることを特徴とする、原発性骨腫瘍の診断支援システム。 【選択図】図1
Nº publicación: EP4725400A1 15/04/2026
Solicitante:
OURA HEALTH OY [FI]
Resumen de: EP4725400A1
Methods, systems, and devices for optical signal measurement are described. A wearable electronic device may activate a first combination of optical sensors, the first combination of optical sensors including a set of transmitter sensors and a set of receiver sensors. In some cases, one or more optical sensor of the first combination of optical sensors may be positioned under a protrusion on an inner surface of the wearable electronic device. The device may measure, at the set of receiver sensors at a first time, one or more signals from the set of transmitter sensors, determine a signal quality metric associated with the one or more signals, and select a second combination of optical sensors for use at a second time based on the signal quality metric.